Literature DB >> 8370167

Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.

K M Dolman1, C A Stegeman, B A van de Wiel, C E Hack, A E von dem Borne, C G Kallenberg, R Goldschmeding.   

Abstract

In the sera of patients with Wegener's granulomatosis (WG), C-ANCA can be detected that are directed against proteinase 3 (PR3). We have previously observed that C-ANCA interfere with PR3 proteolytic activity and with complexation of PR3 with its major physiologic inhibitor, alpha 1-antitrypsin (alpha 1AT). In the present study we investigated whether this inhibitory effect of C-ANCA on PR3-alpha 1AT complexation correlates with clinical activity of WG. Serial serum samples of eight consecutive patients with histologically proven relapses of WG were tested. At the moment of relapse all sera revealed inhibitory activity towards PR3-alpha 1AT complexation (median 22%, range 10-59%). Disease activity score (r = 0.87, P < 0.02) and C-reactive protein (CRP) levels (r = 0.66, P < 0.1) correlated with C-ANCA inhibition of PR3-alpha 1AT complexation, while they did not correlate with the C-ANCA titre detected by indirect immunofluorescence (IIF) nor with IgG anti-PR3 antibody level measured by ELISA. The inhibitory effect of C-ANCA on PR3-alpha 1AT complexation had risen significantly at the moment of relapse compared with values 3 months (P < 0.05) and 6 months (P < 0.01) before relapse. Eight patients with established WG and positive for C-ANCA but without clinical evidence of relapse served as controls. In this group no inhibitory effect of C-ANCA on PR3-alpha 1AT complexation was observed in 7/8 patients sera. Sera of one control patient contained moderate C-ANCA inhibitory activity towards PR3-alpha 1AT complexation, which remained at a constant level during the 6 months period of observation. Thus, disease activity in WG appears to be more closely related to C-ANCA inhibitory activity towards PR3-alpha 1AT complexation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370167      PMCID: PMC1554914          DOI: 10.1111/j.1365-2249.1993.tb08192.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.

Authors:  A Wiik
Journal:  APMIS Suppl       Date:  1989

2.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

Authors:  J W Tervaert; F J van der Woude; A S Fauci; J L Ambrus; J Velosa; W F Keane; S Meijer; M van der Giessen; G K van der Hem; T H The
Journal:  Arch Intern Med       Date:  1989-11

3.  Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters.

Authors:  R C Kao; N G Wehner; K M Skubitz; B H Gray; J R Hoidal
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

Authors:  J L Niles; R T McCluskey; M F Ahmad; M A Arnaout
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

5.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

6.  Determination of proteinase 3-alpha 1-antitrypsin complexes in inflammatory fluids.

Authors:  K M Dolman; B A van de Wiel; C M Kam; J J Abbink; C E Hack; A Sonnenberg; J C Powers; A E von dem Borne; R Goldschmeding
Journal:  FEBS Lett       Date:  1992-12-14       Impact factor: 4.124

Review 7.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

8.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

9.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

Authors:  R Goldschmeding; C E van der Schoot; D ten Bokkel Huinink; C E Hack; M E van den Ende; C G Kallenberg; A E von dem Borne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

10.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

Authors:  J Lüdemann; B Utecht; W L Gross
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  16 in total

1.  Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis.

Authors:  B F Bruner; E S Vista; D M Wynn; J B Harley; J A James
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

2.  Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.

Authors:  Y M Van Der Geld; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.

Authors:  Francisco Silva; Amber M Hummel; Dieter E Jenne; Ulrich Specks
Journal:  J Autoimmun       Date:  2010-12       Impact factor: 7.094

4.  Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.

Authors:  A H Mulder; C A Stegeman; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 5.  B cell epitope specificity in ANCA-associated vasculitis: does it matter?

Authors:  Y M van der Geld; C A Stegeman; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

6.  Recombinant proteinase 3 (Wegener's antigen) expressed in Pichia pastoris is functionally active and is recognized by patient sera.

Authors:  M C Harmsen; P Heeringa; Y M van der Geld; M G Huitema; A Klimp; A Tiran; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

7.  Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis.

Authors:  Mårten Segelmark; Brian D Phillips; Susan L Hogan; Ronald J Falk; J Charles Jennette
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

8.  Alpha 1-antitrypsin activity is markedly decreased in Wegener's granulomatosis.

Authors:  Ali Mota; Abbas Sahebghadam Lotfi; Ahmad-Reza Jamshidi; Saeed Najavand
Journal:  Rheumatol Int       Date:  2013-04-19       Impact factor: 2.631

9.  The avidity of PR3-ANCA in patients with granulomatosis with polyangiitis during follow-up.

Authors:  M J Kemna; W Schlumberger; P van Paassen; C Dähnrich; J G M C Damoiseaux; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

10.  Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology.

Authors:  Agnieszka A Rarok; Ymke M van der Geld; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.